Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.
about
Targeting cancer-related inflammation: Chinese herbal medicine inhibits epithelial-to-mesenchymal transition in pancreatic cancerProstate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristicsLoss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancerChronic inflammation and cytokines in the tumor microenvironment.Acute inflammation induced by the biopsy of mouse mammary tumors promotes the development of metastasis.Bone marrow endothelium-targeted therapeutics for metastatic breast cancerDefining a role for acid sphingomyelinase in the p38/interleukin-6 pathway.Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical studyThe PCa Tumor Microenvironment.Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-ĸB signaling, and synergizes with an ERK inhibitorCombination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell linesStromal-Initiated Changes in the Bone Promote Metastatic Niche Development.Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulationAscorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice.Significance of Interleukin-6 in Papillary Thyroid Carcinoma.Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancersOsteoclasts-Key Players in Skeletal Health and Disease.Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.Cancer-Osteoblast Interaction Reduces Sost Expression in Osteoblasts and Up-Regulates lncRNA MALAT1 in Prostate Cancer.Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation.Skeletal metastasis: treatments, mouse models, and the Wnt signaling.Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer.Cyclooxygenase-2 in tumor-associated macrophages promotes metastatic potential of breast cancer cells through Akt pathway.Hepatitis B virus X protein in liver tumor microenvironment.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines.The pattern of GPI-80 expression is a useful marker for unusual myeloid maturation in peripheral blood.A Paracrine Role for IL6 in Prostate Cancer Patients: Lack of Production by Primary or Metastatic Tumor Cells.Liposomal delivery of dexamethasone attenuates prostate cancer bone metastatic tumor growth in vivo.Cytokines in Endocrine Dysfunction of Plasma Cell Disorders.Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression.Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.Prostate cancer health disparities: An immuno-biological perspective.Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain.Alterations in NO- and PGI2- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation.Pro-apoptotic effects of Kangfuxin on human stomach cancer cells and its underlying mechanism.Zoledronic Acid Elicits Proinflammatory Cytokine Profile in Osteolytic Prostate Cancer Cells
P2860
Q21132666-1DBCC643-76F5-4280-A599-4FB148BD94A1Q26773613-DDF000FA-31C5-4AA7-A0B5-464BDB5B7772Q28535183-258243A6-4B01-4AF4-A286-C2F0EE754951Q33678275-C2C6D155-C0DC-4FD8-9DD7-475F15B1630AQ33683707-3779E0C4-7AA1-43E3-A471-237D4A0FCF9CQ33943576-3465B6A9-6579-48F2-9C51-E27334C94A3EQ34070467-E64FA923-DB43-4FFD-8E9C-30B08AF23423Q34781112-5C30C8A1-814B-4642-8726-55AD5971D6D6Q35603143-3E8465E3-3BC5-48C4-8012-F93574EF1AE8Q35925413-91733FE3-2596-457A-B46E-AA6EB3DC642AQ35928999-95E9917E-626B-45C3-A2F6-78ECFE40B7DCQ36446714-1B1F2D27-45D9-45CC-BE73-6D6F25C03A52Q36562147-AC573E03-9ECC-437D-8E96-F64674EC95D2Q36642930-F1EEDEA1-9747-4397-AF76-FC7BAE6FBFEBQ36731164-E823803E-3426-4816-93A5-802F429B9AD5Q36862773-412FE720-0F4D-4651-BC7C-82009D5A5BD7Q37036135-F4E2D7BA-37DE-4DDB-93BD-50FAF9B3BB9BQ37200413-8359818A-3311-43E9-A831-129D6A2677BEQ37200829-E272A308-DF44-437F-BD32-FBF67FE55547Q37262555-2A4F78A9-9941-44B9-BFD6-F7D8DAC086C2Q37354085-CEA3593D-6BDB-40D9-B2B4-A4E1DBDD710FQ37402732-F37315B1-E1E8-4E1A-80B8-D852E57639DFQ37513938-3512D21A-DC67-4B05-AEED-467DF16D9854Q37596738-40A2449E-6891-433C-9927-CBD117AFA41CQ37615017-B7700CCE-2ACC-408B-84DB-DD4FB10A1392Q37660315-6B5CEF47-73A1-455D-96D2-DFDA324C0EA6Q37968599-EA276627-66E2-4153-9622-85583E2A76C5Q38690169-3BCCD964-EEF9-49FB-9E6D-D142D2E3E465Q38749477-875F631B-5832-4F64-8A43-AD5C4BD84023Q38866860-45356D70-BF68-4B19-B896-B738B3684BDFQ38911659-3F16395C-C001-4342-8329-DF1AED8BD12DQ39455586-FAB54157-B220-4E80-B535-A26F3FAE2B91Q42729905-B37B1F58-B12D-4C81-ADF9-3AF3EF18AF36Q43111820-78E4FB39-0659-46F5-8E60-78EFAD21A0EDQ46537204-90964878-8596-4266-A687-0CCFC34A64C6Q47557846-40575D9C-C6F8-4783-B58D-B9493608C299Q55081573-C1325887-B8A8-4C9F-9AF2-435E76F93DBBQ55406485-6DD85609-54E9-43F7-836C-C3B500B9FD34Q59047122-7F0A58B8-1274-49BD-AD1A-064BA016F8FA
P2860
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical significance of inter ...... ential of anti-IL-6 therapies.
@ast
Clinical significance of inter ...... ential of anti-IL-6 therapies.
@en
type
label
Clinical significance of inter ...... ential of anti-IL-6 therapies.
@ast
Clinical significance of inter ...... ential of anti-IL-6 therapies.
@en
prefLabel
Clinical significance of inter ...... ential of anti-IL-6 therapies.
@ast
Clinical significance of inter ...... ential of anti-IL-6 therapies.
@en
P2860
P356
P1476
Clinical significance of inter ...... ential of anti-IL-6 therapies.
@en
P2093
Ken Tawara
P2860
P304
P356
10.2147/CMR.S18101
P407
P577
2011-05-18T00:00:00Z